Trial
NCT03722680
Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy.
Phase IISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
UNICANCER
Collaborators
—
Condition
Oxaliplatin-induced Peripheral Neuropathy
Intervention
Riluzole
Why stopped
Lack of treatment, sponsor decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-20